What are the consequences of conducting clinical trials of medicines in poor countries as per the Supreme Court
Supreme Court raises concerns about clinical trials being often conducted in poor countries.
- Concerns about ethical considerations and exploitation of vulnerable populations in poor countries for clinical trials.
- Risk of inadequate regulatory oversight and enforcement of standards in these countries.
- Potential lack of access to proper healthcare and follow-up care for trial participants in case of adverse effects.
- Inequalities in access to benefits of the trials, such as new treatments or drugs, between participants in poor countries and those in wealthier nations.
- Possible distortion of trial results due to differences in healthcare systems and demographics between poor countries and developed countries.
- Calls for stricter regulations and guidelines to ensure fair and ethical conduct of clinical trials in all countries.
Answered
4 months ago